Invesaro

Stocks Health care KRMD

NASDAQ · Health care

KORU Medical Systems, Inc. (KRMD)

KORU Medical Systems, Inc. brought in $45.1M of revenue over the twelve months to June 30, 2026, up 22.4% from a year earlier. It posted a net loss of $1.8M. In fiscal 2025 capital spending exceeded operating cash flow by $470.1K. At June 30, 2026 it held $8.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

Free, no password. An email when KRMD files with the SEC.

Price
$3.15
-2.48% on the day · November 10, 2026
52-week range $2.86 to $6.61
Market cap
$145.4M
Revenue (last 12 months)
$45.1M
+22.4% year on year
Net margin
-4.0%

Key facts about KORU Medical Systems, Inc.

Net worth
KORU Medical Systems, Inc. has a market value (market cap) of $145.4M at the latest share price, and shareholders' equity of $18.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $41.1M (+22.2% year on year), with a net loss of $2.6M. Over the 12 months to June 30, 2026: revenue $45.1M, net loss $1.8M.
Cash flow
In fiscal 2025 operations brought in $462.4K of cash; after $932.5K of capital spending, free cash flow was -$470.1K.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
KORU Medical Systems, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What KORU Medical Systems, Inc. does

KORU Medical Systems, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker KRMD.

Revenue and profit by year

Revenue
FY18: $17.4M $17.4M FY18FY19: $23.2M $23.2M FY19FY20: $24.2M $24.2M FY20FY21: $23.5M $23.5M FY21FY22: $27.9M $27.9M FY22FY23: $28.5M $28.5M FY23FY24: $33.6M $33.6M FY24FY25: $41.1M $41.1M FY25
Net income
FY18: $910.6K $910.6K FY18FY19: $564.3K $564.3K FY19FY20: -$1.2M -$1.2M FY20FY21: -$4.6M -$4.6M FY21FY22: -$8.7M -$8.7M FY22FY23: -$13.7M -$13.7M FY23FY24: -$6.1M -$6.1M FY24FY25: -$2.6M -$2.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$41.1M-$3M-$2.6M-$0.06-$470.1K
2024$33.6M-$6.4M-$6.1M-$0.13-$1.6M
2023$28.5M-$10.3M-$13.7M-$0.30-$5.7M
2022$27.9M-$10.8M-$8.7M-$0.19-$8.2M
2021$23.5M-$7M-$4.6M-$0.10-$4.7M
2020$24.2M-$1.3M-$1.2M-$0.03-$1.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where KRMD ranks in Health care

Revenue$41.1M
#413 of 751 in Health care · Bottom 45%
Revenue growth+22.2%
#166 of 532 in Health care · Top 31%
Net margin-6.4%
#259 of 544 in Health care · Top 48%
Free cash flow margin-1.1%
#248 of 490 in Health care · Bottom 49%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What KORU Medical Systems, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
  2. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 18% to $12M versus the same quarter last year; diluted EPS $0.01 versus $0.00.
  3. August 5, 2026
  4. July 29, 2026
  5. June 30, 2026
  6. May 21, 2026
  7. May 6, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 22% to $11.8M versus the same quarter last year; diluted EPS -$0.02 versus -$0.03.
  8. May 6, 2026
  9. April 27, 2026
  10. April 9, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 1, 2026. Insider transactions on SEC

Insider trades

What the people running KORU Medical Systems, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $101.1K worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$101.1K
last 90 days
Sold
$0
last 90 days
Net bought
32,000
$101.1K
DateInsiderWhatSharesPriceValueFiling
October 1, 2026 Cascella RobertDirector Received as pay 5,119 $2.93 $15K Form 4
October 1, 2026 Fletcher R JohnDirector Received as pay 7,679 $2.93 $22.5K Form 4
October 1, 2026 French DonnaDirector Received as pay 5,119 $2.93 $15K Form 4
October 1, 2026 Matin ShahriarDirector Received as pay 5,119 $2.93 $15K Form 4
October 1, 2026 Wholihan EdwardDirector Received as pay 5,119 $2.93 $15K Form 4
September 30, 2026 Manko Joseph M. Jr.Director, 10% owner Received as payindirect 5,119 - - Form 4
September 8, 2026 Kalbermatten Adam RChief Commercial Officer Bought 32,000 $3.16 $101.1K Form 4
July 28, 2026 Kalbermatten Adam RChief Commercial Officer Exercised options 75,000 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns KRMD

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Joseph M. Manko, Jr.13D, may seek influence with 3 related filers 12.62% 5,845,045 February 13, 2026
Topline Capital Management, LLC13G, passive with 2 related filers 8.5% 3,941,014 February 13, 2026
Mathew P. Arens13G, passive with 1 related filers 8.27% 3,831,475 February 17, 2026

Latest filings below 5%: Archon Capital Management LLC 0.4% (November 13, 2024).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

11 insiders reported holding 8,421,211 shares in total, about $26.5M at the last price.

HolderSharesAs of
Manko Joseph M. Jr.Director, 10% owner 5,857,2075,074,660 held indirectly September 30, 2026
Kalbermatten Adam RPresident-Chief Commercial Off 706,517 September 8, 2026
Tharby Linda MChief Executive Officer, Director 620,622 May 15, 2026
Adams Thomas EdwardChief Financial Officer 313,440 May 14, 2026
Pazdan ChristopherChief Operating Officer 308,988 May 14, 2026
Fletcher R JohnDirector 239,836 October 1, 2026
Matin ShahriarDirector 106,263 October 1, 2026
French DonnaDirector 103,633 October 1, 2026
Cascella RobertDirector 103,274 October 1, 2026
Wholihan EdwardDirector 56,431 October 1, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about KRMD

What does KORU Medical Systems, Inc. do?

KORU Medical Systems, Inc. is a company in the Health care sector, listed on NASDAQ as KRMD. Its shares trade on NASDAQ under the ticker KRMD.

What is KORU Medical Systems, Inc.'s net worth?

KORU Medical Systems, Inc. has a market value (market cap) of $145.4M at the latest share price, and shareholders' equity of $18.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is KORU Medical Systems, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $1.8M on revenue of $45.1M.

How much revenue does KORU Medical Systems, Inc. make?

Over the twelve months to June 30, 2026 KORU Medical Systems, Inc. reported revenue of $45.1M. That is 22.4% more than a year earlier.

When did KORU Medical Systems, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 1, 2026.

When is KORU Medical Systems, Inc.'s next earnings report?

KORU Medical Systems, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare KRMD with

Compare KRMD with any company

Follow KRMD

Get an email when KORU Medical Systems, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when KRMD files with the SEC.

Where the numbers come from

Financial figures are the values KORU Medical Systems, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.